Go Pro
NASDAQ:MDLN

Medline (MDLN) Stock Price, News & Analysis

Medline logo
$33.81 -1.42 (-4.03%)
As of 04:00 PM Eastern

About Medline Stock (NASDAQ:MDLN)

Advanced

Key Stats

Today's Range
$33.53
$35.32
50-Day Range
$33.19
$43.19
52-Week Range
$32.81
$50.88
Volume
9.68 million shs
Average Volume
6.94 million shs
Market Capitalization
$44.42 billion
P/E Ratio
105.66
Dividend Yield
N/A
Price Target
$48.46
Consensus Rating
Moderate Buy

Company Overview

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations. Its offerings typically include direct delivery, customized kit and procedure-packaging services, inventory management programs and value‑added services such as clinical education and operational consulting. These capabilities are aimed at improving clinical workflow and supporting large, complex supply networks.

Medline operates through an extensive distribution network and serves customers across multiple geographies, with a primary focus on North American healthcare markets alongside international sales and distribution activity. The company is run by an executive leadership team responsible for its commercial, operational and clinical service lines. As a company listed on the NASDAQ under the symbol MDLN, Medline positions itself as an integrated supplier and supply‑chain partner for the healthcare industry.

AI Generated. May Contain Errors.

Medline Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
91st Percentile Overall Score

MDLN MarketRank™: 

Medline scored higher than 91% of companies evaluated by MarketBeat, and ranked 40th out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medline has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 1 strong buy rating, 22 buy ratings, 5 hold ratings, and 1 sell rating.

  • Upside Potential

    Medline has a consensus price target of $48.46, representing about 43.3% upside from its current price of $33.81.

  • Amount of Analyst Coverage

    Medline has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Medline's stock forecast and price target.
  • Earnings Growth

    Earnings for Medline are expected to grow by 7.38% in the coming year, from $1.49 to $1.60 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medline is 105.66, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.45.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medline is 105.66, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 269.75.

  • Price to Earnings Growth Ratio

    Medline has a PEG Ratio of 3.07. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Medline has a P/B Ratio of 2.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.26% of the float of Medline has been sold short.
  • Short Interest Ratio / Days to Cover

    Medline has a short interest ratio ("days to cover") of 4.48.
  • Change versus previous month

    Short interest in Medline has recently decreased by 18.86%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Medline does not currently pay a dividend.

  • Dividend Growth

    Medline does not have a long track record of dividend growth.

  • News Sentiment

    Medline has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 38 news articles for Medline this week, compared to 8 articles on an average week.
  • Search Interest

    14 people have searched for MDLN on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added Medline to their MarketBeat watchlist in the last 30 days. This is an increase of 267% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medline insiders have sold 48,892.18% more of their company's stock than they have bought. Specifically, they have bought $170,750.00 in company stock and sold $83,654,149.00 in company stock.

  • Percentage Held by Insiders

    0.81% of the stock of Medline is held by insiders.

  • Percentage Held by Institutions

    Medline has minimal institutional ownership at this time.

  • Read more about Medline's insider trading history.
Receive MDLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medline and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDLN Stock News Headlines

Truist Financial Cuts Medline (NASDAQ:MDLN) Price Target to $47.00
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
Private Ltd Gic Sells 271,994 Shares of Medline (NASDAQ:MDLN) Stock
Stifel Nicolaus Cuts Medline (NASDAQ:MDLN) Price Target to $45.00
See More Headlines

MDLN Stock Analysis - Frequently Asked Questions

Medline's stock was trading at $42.00 at the start of the year. Since then, MDLN shares have decreased by 19.5% and is now trading at $33.81.

Medline (NASDAQ:MDLN) posted its quarterly earnings data on Wednesday, August, 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.18. The business earned $7.69 billion during the quarter.
Read the conference call transcript
.

Medline (MDLN) raised $7 billion in an IPO on Wednesday, December 17th 2025. The company issued 248,439,654 shares at a price of $26.00-$30.00 per share.

Medline's lock-up period expired on Monday, June 15th. Medline had issued 216,034,482 shares in its IPO on December 17th. The total size of the offering was $6,264,999,978 based on an initial share price of $29.00. Since the expiration of the company's lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company have been lifted.

Top institutional investors of Medline include Bank of New York Mellon Corp (0.08%), E. Ohman J or Asset Management AB, PensionDanmark Pensionsforsikringsaktieselskab and GAMMA Investing LLC. Insiders that own company stock include Group Vii S1 LLC Tc, Aggregator Lp Mozart II, Cp Circle Ml Holdco Gp, Llc, Carlyle Group Inc, Mozart Coinvestment Ho Carlyle, Tc Group Cayman Investment Hol, Private Ltd Gic, Andrew J Mills, Charles N Mills, Hellman & Friedman Capital Par, Douglas P Golwas and Jessi L Corcoran.
View institutional ownership trends
.

Shares of MDLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/05/2026
Today
8/10/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:MDLN
CIK
2046386
Fax
N/A
Employees
45,000
Year Founded
1966

Price Target and Rating

High Price Target
$62.00
Low Price Target
$37.00
Potential Upside/Downside
+43.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.79
Research Coverage
29 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
105.66
Forward P/E Ratio
22.69
P/E Growth
3.07
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
4.33
Quick Ratio
2.61

Sales & Book Value

Annual Sales
$28.43 billion
Price / Sales
1.56
Cash Flow
$1.63 per share
Price / Cash Flow
20.77
Book Value
$14.68 per share
Price / Book
2.30

Miscellaneous

Outstanding Shares
1,313,690,000
Free Float
1,303,047,000
Market Cap
$44.42 billion
Optionable
N/A
Beta
N/A

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:MDLN) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners